Skip to Content
Merck
All Photos(2)

Documents

GF62158596

Lithium

foil, not light tested, 38x200mm, thickness 0.20mm, as rolled, 99.9%

Synonym(s):

Lithium, LI000220

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
Li
CAS Number:
7439-93-2
Molecular Weight:
6.94
MDL number:
MFCD00134051
UNSPSC Code:
12141803
PubChem Substance ID:
329809388
NACRES:
NA.23

Assay

99.9%

form

foil

manufacturer/tradename

Goodfellow 621-585-96

resistivity

9.446 μΩ-cm, 20°C

size × thickness

38x200 mm × 0.20 mm

bp

1342 °C (lit.)

mp

180 °C (lit.)

density

0.534 g/mL at 25 °C (lit.)

SMILES string

[Li]

InChI

1S/Li

InChI key

WHXSMMKQMYFTQS-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Storage Class Code

4.3 - Hazardous materials which set free flammable gases upon contact with water

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yingying Lu et al.
Nature materials, 13(10), 961-969 (2014-08-12)
Rechargeable lithium, sodium and aluminium metal-based batteries are among the most versatile platforms for high-energy, cost-effective electrochemical energy storage. Non-uniform metal deposition and dendrite formation on the negative electrode during repeated cycles of charge and discharge are major hurdles to
Rasmus W Licht
CNS neuroscience & therapeutics, 18(3), 219-226 (2011-11-11)
Still after more than 50 years, lithium is a major treatment of bipolar disorder, even though it has not been promoted by the pharmaceutical industry over the last decades. In recent years the evidence base on lithium for bipolar disorder
Mustafa Khasraw et al.
BMC medicine, 10, 131-131 (2012-11-06)
Neurocognitive impairment is being increasingly recognized as an important issue in patients with cancer who develop cognitive difficulties either as part of direct or indirect involvement of the nervous system or as a consequence of either chemotherapy-related or radiotherapy-related complications.
Annemiek Dols et al.
International clinical psychopharmacology, 28(6), 287-296 (2013-07-23)
Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects
P Sienaert et al.
Journal of affective disorders, 146(1), 15-33 (2012-09-05)
Throughout the past decades, several methods have been developed to achieve therapeutic lithium blood levels as quick and safe as possible. The present study will systematically review the methods developed and studied for lithium dose estimation or level prediction at
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service